GynTect

quickly get a reliabe diagnosis

Innovation for laboratories

GynTect.

GynTect.

reliable diagnosis

Questions regarding GynTect?

Get the answers!

Welcome at oncgnostics GmbH Jena

Reliable cancer diagnosis

Development of molecular assays based on epigenetic biomarkers which allow early and reliable cancer diagnostics – this is the intention of oncgnostics!

Improve diagnosis

Our products should allow an early detection of diseases to substantially inprove therapy success. Notice: if detected early, almost all cancer cases are curable.

Newsletter

If you would like us to keep you informed about news related to our company, please sign in for our quarterly newsletter.

News

EierstockkrebsShutterstock

Ovarian cancer: The silent danger

Every year, about 7,300 women in Germany are diagnosed with ovarian cancer (ovarian carcinoma), and more than 5,000 die of the consequences. This means that one in 72 women will be diagnosed with ovarian cancer at some point in their lives.…
Read more

Epigenetic markers – definition and significance for early cancer detection

As a biotechnology company, we have been researching cancer diagnostics on a molecular basis since 2012. We deal with epigenetic markers, which help us to recognise cancers, such as cervical cancer, in their preliminary stages. In this article,…
Read more
"HPV-Vorsorge durch Selbsttests in die eigene Hand nehmen" - Auf dem Bild sind Hände zu sehen, in denen die Buchstaben für HPV liegen.shutterstock.com 1936727821

Pilot study: Cancer screening from home is possible

A large proportion of women who develop cervical cancer in high-income countries such as Germany do not regularly attend screening. This is particularly alarming, as cancer screenings have become much less frequent since the onset of the corona…
Read more

oncgnostics GynTect

Our fist product, GynTect®, enables reliable and fast diagnosis of cervical cancer and pre-cancerous stages.

Show Product

Video in German.